Cancer Research Group Fears Hiring Freeze May Hurt FDA Oncology Center

By Beth Wang / February 2, 2017 at 9:05 PM
A cancer patient advocate worries that President Donald Trump's hiring freeze could put a crimp in FDA's newly launched Oncology Center of Excellence (OCE), an initiative aimed at speeding patient access to cancer treatments and which is viewed as a possible model for creation of other disease-focused centers in the future. FDA formally launched OCE Thursday (Jan. 19) as part of the Cancer Moonshot Initiative. While the new center is expected to streamline approvals of cancer products, it will require...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.